BRK.B vs GILD · rev $371.44B vs P/E 18, rev $7.80B
BRK.B (BRK.B) versus Gilead Sciences Inc (GILD) — a side-by-side from cached financials, not a winner call.
BRK.B (BRK.B) common stock. It is led by Warren Buffett.
Gilead Sciences Inc (GILD) is a drug manufacturers - general company listed on US. It is led by Daniel P. O'Day.
Latest reported BRK.B revenue for 2025-12-31 was $371.44B. Net income was $66.97B. Revenue was up 616.8% from 2015-12-31 to 2025-12-31. BRK.B currently screens at market cap $0.
Latest reported GILD revenue for 2026-06-30 was $7.80B. Net income was -$10.50B. Revenue was up 12.1% from 2026-03-31 to 2026-06-30. GILD currently screens at market cap $160.15B and trailing P/E 17.5.
BRK.B currently screens at market cap $0. GILD currently screens at market cap $160.15B and trailing P/E 17.5.
Not investment advice. Open the BRK.B and GILD stock pages for the full models.
Not investment advice.